Clinical Trial Update: Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a conditioning regimen followed by donor bone marrow or stem cell transplant in patients with primary immunodeficiency and noncancerous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Genetic Disorder
• Immunodeficiency Syndrome

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine phosphate (Fludarabine phosphate)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)
• Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Immunodeficiency Syndrome, Severe Aplastic Anemia | Phase 2 | Status: TERMINATED | Results posted: 2021-01-26